Abstract
In the original version of this article (1), the authors did not disclose that the investigational agent used, tadalafil, was supplied by Lilly, Inc. This information is now included in the Acknowledgements. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.
Cite
CITATION STYLE
Califano, J. A., Khan, Z., Noonan, K. A., Rudraraju, L., Zhang, Z., Wang, H., … Borrello, I. (2018, December 1). Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma(Clin Cancer Res (2015)21(30–8)DOI: 10.1158/1078-0432.CCR-14-1716). Clinical Cancer Research. American Association for Cancer Research Inc. https://doi.org/10.1158/1078-0432.CCR-18-3298
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
